Department of Surgery, Stony Brook University Medical Center, Stony Brook, NY, USA.
J Am Coll Surg. 2013 Mar;216(3):412-9. doi: 10.1016/j.jamcollsurg.2012.11.009. Epub 2013 Jan 11.
Readmission within 30 days of adult cardiac surgery procedures is a frequent contributor to the costs of cardiac surgery hospitalizations, but current data regarding risk factors for readmission are limited. We therefore sought to analyze quality improvement risk factors for readmissions after coronary bypass surgery (CABG).
The records of patients undergoing CABG at our institution from July 2006 to June 2011 were evaluated for variables with potential literature-based associations with readmission, including New York Cardiac Surgery Reporting System (CSRS) risk factors, discharge medications, and laboratory values.
The readmission rate was 13% (n = 158 of 1,205); the CSRS predicted rate was 8.7% (observed/expected ratio = 1.5). Median time from CABG discharge to readmission was 6 days (interquartile range [IQ] 3 to 13 days). Median readmission length of stay was 4 days (IQ 2 to 7 days). The most frequent reasons for readmission were cardiac (n = 40 [25% of readmissions]) and pulmonary complications, including pleural effusions (n = 36 [23%]). Beyond CSRS risk factors, only abnormal discharge serum creatinine was associated with increased readmission (p = 0.05). Combining CSRS risk variables for government insurance and unplanned reoperation led to the highest readmission risk (odds ratio [OR] 5.7, 95% CI 1.7 to 18.7).
Coronary bypass surgery readmissions remain a persistent clinical challenge. Given that readmissions often occur within the first week postdischarge and are typically of short duration, post-CABG readmissions may be reduced through careful postoperative surveillance for readmission risk factors (eg, abnormal serum creatinine or unplanned reoperations) and/or for frequent causes of readmission (eg, pleural effusions).
成人心脏手术后 30 天内再入院是导致心脏手术住院费用增加的一个常见因素,但目前关于再入院风险因素的数据有限。因此,我们试图分析冠状动脉旁路移植术(CABG)后再入院的质量改进风险因素。
对我院 2006 年 7 月至 2011 年 6 月期间接受 CABG 的患者的记录进行了评估,评估了与再入院有潜在文献关联的变量,包括纽约心脏手术报告系统(CSRS)风险因素、出院药物和实验室值。
再入院率为 13%(n=158/1205);CSRS 预测率为 8.7%(观察/预期比=1.5)。从 CABG 出院到再入院的中位时间为 6 天(四分位间距[IQ]3 至 13 天)。中位再入院住院时间为 4 天(IQ2 至 7 天)。再入院的最常见原因是心脏(n=40[25%的再入院])和肺部并发症,包括胸腔积液(n=36[23%])。除 CSRS 风险因素外,只有异常的出院血清肌酐与再入院风险增加相关(p=0.05)。将政府保险和非计划性再次手术的 CSRS 风险变量结合起来,导致再入院风险最高(比值比[OR]5.7,95%置信区间[CI]1.7 至 18.7)。
冠状动脉旁路移植术再入院仍然是一个持续存在的临床挑战。鉴于再入院通常发生在出院后第一周内,且持续时间通常较短,通过仔细监测再入院风险因素(如血清肌酐异常或非计划性再次手术)和/或再入院的常见原因(如胸腔积液),可以减少 CABG 后的再入院。